Elevian develops regenerative medicines that target root-cause aging mechanisms. We are a spin out from Harvard, led by a team of serial entrepreneurs and Harvard scientists.
Elevian’s founders have identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms. One well published example, GDF11, reduces age-related cardiac hypertrophy, accelerates skeletal muscle repair, and improves cognitive function in aged mammals. We are developing biotherapeutics that regulate these blood factors.
By targeting root-cause aging mechanisms, Elevian's therapeutics have the potential to treat or prevent multiple degenerative diseases and extend healthy lifespan.
Location: United States, Massachusetts, Boston
Employees: 11-50
Total raised: $95M
Founded date: 2017
Investors 4
| Date | Name | Website |
| - | Western Te... | westerntec... |
| - | Bold Capit... | boldcapita... |
| - | Formic Ven... | formic.vc |
| - | For Good V... | forgoodven... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 03.12.2021 | Series A | $40M | - |
| 16.09.2021 | Series A | $40M | - |
| 24.11.2020 | - | $15M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 10.03.2023 | Tweekly. Выпуск 160. Бессмертие как сервис... | Что сейчас растёт и как это применить 1. Бессмертие как сервис (IaaS). То, чего все хотят и боятся о... | vc.ru/u/24... |
| 05.11.2021 | Kuelbs Family Office Invests in Biotech Company Elevian, Sup... | DALLAS (PRWEB) November 05, 2021 Texas-based investor John A. Kuelbs announces his commitment to tra... | prweb.com/... |
| 17.09.2021 | Elevian snags $40M for stroke recovery and age-related disea... | Elevian thinks it has the tools to treat age-related diseases and will start by testing its drug in ... | fiercebiot... |
| 17.09.2021 | When startup exits aren’t such good news | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 17.09.2021 | Elevian snags $40M for stroke recovery and age-related disea... | - | boldcapita... |
| 17.09.2021 | When startup exits aren’t such good news | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign ... | fortune.co... |
| 17.09.2021 | Elevian snags $40M for stroke recovery and age-related disea... | Elevian thinks it has the tools to treat age-related diseases and will start by testing its drug in ... | fiercebiot... |
| 17.09.2021 | Elevian Raises $40M Series A | ALLSTON, MA, Elevian, an emerging biotech company, has raised $40 million in an oversubscribed Ser... | vcnewsdail... |
| 16.09.2021 | Elevian Raises $40 Million Series A to Advance Treatments fo... | - | boldcapita... |
| 16.09.2021 | Elevian Raises $40 Million Series A to Advance Treatments fo... | prnewswire... |
Show more